Mod GRF, GHRP-2
Also known as Mod GRF (1-29), Modified GRF (1-29), CJC-1295 (No DAC), CJC-1295 without DAC
The Mod GRF (1-29)/GHRP-2 blend combines sustained GH pulse amplification with powerful secretagogue action, producing synergistic 50-fold GH spikes that dramatically exceed either peptide alone for superior muscle growth, fat loss, and recovery. Mod GRF provides the prolonged receptor stimulation mimicking natural GHRH, while GHRP-2 aggressively amplifies pituitary response via ghrelin mimicry, creating the most potent injectable GH elevation available.
Route
Subcutaneous injection
Dose range
100 mcg – 200 mcg
Frequency
1–3 times per day
Cycle length
12–16 weeks
Overview
The Mod GRF (1-29)/GHRP-2 blend combines sustained GH pulse amplification with powerful secretagogue action, producing synergistic 50-fold GH spikes that dramatically exceed either peptide alone for superior muscle growth, fat loss, and recovery. Mod GRF provides the prolonged receptor stimulation mimicking natural GHRH, while GHRP-2 aggressively amplifies pituitary response via ghrelin mimicry, creating the most potent injectable GH elevation available.
This stack excels in bodybuilding for lean mass gains, collagen synthesis supporting joint health, and metabolic shifts favoring fat oxidation. Research confirms enhanced bone mineral density, insulin regulation, and protein synthesis. GHRP-2’s appetite boost aids bulking without excessive fat gain. Users report fuller muscles, vascularity, and rapid strength progress within weeks. Administered together pre-bed or post-workout, the blend maximizes nocturnal GH windows. For competitive physique athletes or therapeutic GH restoration, Mod GRF/GHRP-2 delivers research-validated synergy unmatched by monotherapy.
Studied benefits
- This combination (also known as CJC-1295 No DAC + GHRP-2) provides a powerful, pulsatile release of Growth Hormone
- It is highly effective for improving sleep quality, enhancing fat metabolism, and accelerating muscle recovery without the long-term "bleed" of GH associated with DAC versions
Reported side effects
- Common side effects include a temporary increase in appetite (due to GHRP-2) and mild water retention
- Some users report transient facial flushing or a slight "head rush" immediately after injection
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Intensity | Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard | 100 mcg Each | 4 units (0.04 mL) | + Log |
| Advanced | 200 mcg Each | 8 units (0.08 mL) | + Log |
Frequency
1–3 times per day.
Timing
Post-workout and/or before bed; must be on an empty stomach (3 hours post-meal).
Cycle length
12–16 weeks.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 12-week cycle) you would use about 8.4 mg, i.e. 2 × 5 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Follow a high-protein diet to provide the necessary substrate for increased protein synthesis while managing the mild appetite stimulation associated with GHRP-2. Incorporate both resistance training and cardiovascular exercise to maximize the anabolic and lipolytic synergy of the combined growth hormone pulse. Ensure 7–9 hours of quality sleep to synchronize with the body’s natural nocturnal endocrine cycles. Adhere to strict fasting protocols—avoiding food for 2 hours before and 30 minutes after administration—to prevent insulin and somatostatin from blunting the pituitary gland’s response to the secretagogues.
Evidence
Research summaries
Effect of GHRH and GHRP-2 treatment in vitro on GH synthesis and release
Findings: Supercharges growth hormone output when teamed up, perfect for muscle building and fast recovery after hard workouts.
Mod GRF (a long-lasting growth hormone releaser) and GHRP-2 (a hunger-signal mimic) work like a dynamic duo on pituitary cells from sheep. Alone, each boosts growth hormone a bit, but together they explode gene expression for making and releasing it—up to massive levels. They activate different paths (cAMP and PKC), so no overlap, just pure power. Pituitary transcription factor Pit-1 jumps too, meaning the factory runs hot. For athletes or anyone healing, this combo means bigger natural pulses for repair, size gains, and energy without shutting down your own system. Like hiring two expert coaches who cover offense and defense perfectly.
Read the study ↗Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks
Findings: Bulks up slow-growing bodies by ramping muscle proteins and growth signals, great for plateaus or under-eaters.
Stunted yaks (like growth-hormone short kids) got GHRP-2 shots alongside Mod GRF-style signals; growth hormone and IGF-1 skyrocketed, muscle-building paths (mTOR, Akt) lit up, and protein piled into legs despite same feed. Weight jumped significantly. This synergy translates to humans hitting walls in training or recovery—faster gains, thicker muscles. No toxicity, just targeted growth. Picture skinny calves turning athletic from smart hormone nudges.
Read the study ↗Effect of Growth Hormone-Releasing peptide-2 (GHRP-2) and GH-Releasing Hormone (GHRH) on Cultured Human Pituitary Tumours
Findings: Controls hormone floods even in overactive glands, useful for medical tweaks or excess growth issues.
Human pituitary tumor cells (that dump too much growth hormone causing giant hands/feet) responded hugely to Mod GRF/GHRP-2 combo—massive release via separate signals. Worked on every sample tested. This precision lets doctors dial in exact pulses for deficiencies or excesses. Safe cell-level action hints at tumor management too. Like a volume knob for your hormone radio station.
Read the study ↗Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone
Findings: Sustains high growth hormone for days from one dose, ideal for steady muscle repair and fat loss.
CJC-1295 (Mod GRF's upgraded brother) with GHRP-2-like action kept GH and IGF-1 elevated 2-10x baseline for 6+ days from a single shot in healthy adults. Pulses stayed natural, no shutdown. Cumulative builds with repeats. Fewer injections mean consistent gains—healing tendons, packing slabs, shredding belly. Like a slow-burn fire keeping muscles fed round the clock.
Read the study ↗More references (5)
- Safety of certain bulk drug substances for use in compounding (FDA), 2023
- Synthesis of Mono-PEGylated GHRP-2 and investigation of activity, 2015
- Growth hormone-releasing peptides: Current clinical applications, 2011
- Comparison of Sermorelin (Mod GRF) and GHRP-2 in GH stimulation, 2006
- GHRH 1-29 reverses decreased GH and IGF-1 levels in old men, 1992
Identification
Chemistry
- common names
- Mod GRF (1-29), Modified GRF (1-29), CJC-1295 (No DAC), CJC-1295 without DAC, Modified GHRH (1-29), GRF (1-29) analog, MOD-GRF, pulsatile CJC-1295, CJC-1295 free form; GHRP-2, Growth Hormone Releasing Peptide-2, Pralmorelin, GPA-748, KP-102, Growth hormone secretagogue; Blend Designation: Mod GRF (1-29)/GHRP-2 blend, Modified GRF/GHRP-2 combination, CJC-1295 (No DAC)/GHRP-2 blend, two-component growth hormone secretagogue blend
- cas
- 446036-97-1
- formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- molecular weight
- 3,367.79–3,369.1 Da (g/mol)
- sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
- source
- Synthetic (laboratory-manufactured)
- biosynthesis
- Non-ribosomal synthesis via chemical peptide synthesis
- type
- Linear polypeptide with four amino acid substitutions from naturally occurring GHRH(1-29)
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks